USAC appoints Michael A. McManus (age 80) as independent director effective August 2

UNITED STATES ANTIMONY CORP

Michael McManus, former CEO of Misonix and New York Bancorp, joins the board.
McManus served as assistant to the President of the United States (1982-1985) and has been a Novavax board member since 1998.
Chairman Gary Evans stated McManus will help maximize asset value, pursue acquisitions, and provide oversight.
McManus will stand for re-election at the next annual stockholders meeting.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael A. McManus

Independent Director

UAMY · UNITED STATES ANTIMONY CORP

Effective: 2023-08-02
Filed: August 2, 2023, 7:59 PM ET

United States Antimony Corporation (NYSE: UAMY) (“USAC” or the “Company”) announces the addition of Michael A. McManus, age 80, as an Independent Director to its board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael A. McManus was appointed as Independent Director at UNITED STATES ANTIMONY CORP.

Action: appointed
Role: Independent Director

Exact text from the filing

United States Antimony Corporation (NYSE: UAMY) (“USAC” or the “Company”) announces the addition of Michael A. McManus, age 80, as an Independent Director to its board.

View on SEC.gov

UNITED STATES ANTIMONY CORP filing history →

Source: SEC EDGAR

accession 0001654954-23-009981

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.